6.22
price up icon3.67%   0.22
after-market Handel nachbörslich: 6.28 0.06 +0.96%
loading

Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
97.89%
0.1268
6.0022 - - -
Operating Expenses
33.98%
5.6098
4.1871 3.5641 3.2543 2.9001
Benefits Costs and Expenses
5.1788
- - - -
Costs And Expenses
5.1788
- - - -
Operating Income/Loss
402.07%
-5.483
1.8152 -3.5641 -3.2543 -2.9001
Income/Loss From Continuing Operations Before Tax
353.89%
-5.0519
1.9898 -3.422 -3.0954 -2.7365
Income/Loss From Continuing Operations After Tax
499.05%
-5.0519
1.266 -3.422 -3.0954 -2.7365
Net Income/Loss
499.05%
-5.0519
1.266 -3.422 -3.0954 -2.7365
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,878%
14.46
0.2905 9.9479 9.9479 9.7218
Diluted Average Shares
4,878%
14.46
0.2905 9.9479 9.9479 9.7218
Basic Earnings Per Share
333.33%
-0.35
0.15 -0.34 -0.31 -0.28
Diluted Earnings Per Share
333.33%
-0.35
0.15 -0.34 -0.31 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.58
price up icon 1.55%
$35.87
price up icon 1.01%
$24.74
price up icon 7.61%
$96.47
price up icon 0.34%
$111.78
price up icon 0.11%
biotechnology ONC
$255.69
price up icon 4.59%
Kapitalisierung:     |  Volumen (24h):